mRNA Technology Transfer Hub Programme

MPP Logo

The mRNA technology transfer programme is a global initiative that aims to improve health and health security by establishing sustainable, locally owned mRNA manufacturing capabilities in and for low- and middle-income countries (LMICs).

The programme is based around a technology transfer “hub” Afrigen, which is located in South Africa. They will provide the technology development, training and technology transfer, and 15-20 “spokes” in LMICs across the world, will receive training and technology from the hub and then produce and sell products commercially. Its core concept is empowerment.

Initially the programme will focus on mRNA vaccines against COVID-19. However, the programme is designed to encourage the development of other mRNA vaccines and therapeutics against important diseases that threaten LMICs, thereby ensuring the capacity built by the project is sustained and available to combat the next pandemic.


Latest news

News & Communiqués de presse » Évènements

WHA 75 side event on the mRNA Technology Transfer Hub Programme

23 Mai 2022

News & Communiqués de presse » Évènements

Upcoming colloquium: a scientific partnership to enhance mRNA vaccine production

30 juin 2022

News & Communiqués de presse » Évènements

Hybrid Event | mRNA Scientific Colloquium on enhancing mRNA vaccine production

08 juillet 2022

Latest videos


MPP Logo

Abonnez-vous à notre newsletter

Créé et financé par

Unitaid Logo

Autres financements